I wanted to, like, think, okay, I'm in my 30s
Idris I (2017) News and views
Image Credit: DukiPH / Shutterstock.com Introduction Orforglipron is an orally bioavailable next-generation glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA) that has emerged as a potential alternative to injectable agents like semaglutide based on early Phase 1, 2, and 3 clinical trials demonstrating glucose-lowering and weight-loss efficacy without the need for injection-based delivery
This pathway accelerates the approval process and reduces costs because applicants may include data from external studies to establish the safety and efficacy of the already FDA-approved active ingredient
Both guidelines note GLP-1 RAs may improve fertility, ensure contraception counselling before prescribing
Your medical team monitors your progress and makes real-time updates to your plan